Investors

Share

Recently, the Forbes China has released the list of 2011 Forbes China Up and Comers. 200 enterprises were on the list. With the rapid and stable development, Grandhope Biotech has been successfully selected again, ranking 57th this year.

 

It’s the seventh time that Forbes has such a comprehensive and independent investigation during Chinese small and medium-sized enterprises, which includes 20,000 enterprises, with the annual sales between 5million RMB to 1 billion RMB.Basing on the growth index, return index, profitability index, sales and profits, Forbes has selected and ranked the 200 enterprises, including 100 listed firms and 100 unlisted firms.

 

Here’s the links of the list of “2011 Forbes China Up and Comers”:

http://www.forbeschina.com/list/1008/more

More information, please see the website through the links below:

http://www.forbeschina.com/www.3eeezw.com

 

SitemapQR code

Copyright 冠昊生物科技股份有限公司. 粤ICP备12069953号
互联网药品信息服务资格证书编号:(粤)-非经营性-2016-0297